![PDC*line Pharma presents first immunological results from phase I/II trial with PDC*lung01 at ESMO-IO 2022](https://ala.associates/wp-content/uploads/2022/12/20210715-PDCLP-lab2-17-1080x675.jpg)
![PDC*line Pharma presents first immunological results from phase I/II trial with PDC*lung01 at ESMO-IO 2022](https://ala.associates/wp-content/uploads/2022/12/20210715-PDCLP-lab2-17-1080x675.jpg)
![33 Californie launches CaLySeed, new investment fund providing financial and strategic support to healthcare start-ups](https://ala.associates/wp-content/uploads/2022/11/image0000001-e1667898572235-467x675.jpg)
33 Californie launches CaLySeed, new investment fund providing financial and strategic support to healthcare start-ups
![ABL and RD-Biotech sign strategic partnership in cell and gene therapy GMP manufacturing](https://ala.associates/wp-content/uploads/2022/10/ABL-RD-Biotech-signature-1080x675.jpg)
ABL and RD-Biotech sign strategic partnership in cell and gene therapy GMP manufacturing
![admed laboratory adopts QuantaMatrix dRAST solution in routine clinical use](https://ala.associates/wp-content/uploads/2022/10/Dr.-Antony-CROXATTO-987x675.jpg)
admed laboratory adopts QuantaMatrix dRAST solution in routine clinical use
![PDC*line Pharma presents first clinical results from Phase I/II trial with PDC*lung01 at ESMO 2022](https://ala.associates/wp-content/uploads/2022/09/20210715-PDCLP-lab2-17-1080x675.jpg)
PDC*line Pharma presents first clinical results from Phase I/II trial with PDC*lung01 at ESMO 2022
![Yposkesi reinforces team with three executive appointments](https://ala.associates/wp-content/uploads/2022/07/Yposkesi_de-Montgrand_Cambouris_El-Gueddari-appointments-1080x675.jpg)
Yposkesi reinforces team with three executive appointments
![Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product](https://ala.associates/wp-content/uploads/2022/07/MF_portrait-1080x675.jpg)
Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product
![ABL and Coave Therapeutics enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy](https://ala.associates/wp-content/uploads/2022/06/ABL-1080x675.png)
ABL and Coave Therapeutics enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy
![BCI Pharma enters into strategic partnership with Mithra to identify novel therapy for endometriosis and cancer in women](https://ala.associates/wp-content/uploads/2021/12/DOMINIQUE-SURLERAUX.png)
BCI Pharma enters into strategic partnership with Mithra to identify novel therapy for endometriosis and cancer in women
BCI Pharma seeks to expand its library of kinase inhibitors and address innovative mechanisms of action for unmet medical needs
![Contipharma launches saliva-based Omicron detecting PCR test in Africa](https://ala.associates/wp-content/uploads/2021/12/Bernard-Delhez-Copyright-Sudinfo-1080x675.jpg)
Contipharma launches saliva-based Omicron detecting PCR test in Africa
Developed by University of Liège in Belgium, only test of its kind available on African continent
First contracts signed with Democratic Republic of Congo, Burundi and Sudan